Twitter | Search | |
Search Refresh
Giancarlo 3h
What's your have a favourite and where do you buy it from?
Reply Retweet Like
RockPopWelle 16h
Last Airplays: - Vortex - In little Rooms - Turn The Sky - Electrocity
Reply Retweet Like
The RSA Group 3h
Great to see recycling some of it's new-found financial clout into discovery & development via collaboration with . Congratulations to and team for driving forward what is becoming a powerful force in UK medical research.
Reply Retweet Like
Biocompare 19h
This from is bright in western blot, according to a lab tech from Johns Hopkins.
Reply Retweet Like
Biosensors 2019 Jun 17
An is a type of affinity . Specifically detecting the binding between the antigen and and more sensitive to the subtle changes during the antigen interaction.
Reply Retweet Like
Cell Signaling Technology 18h
Need a conjugated for that isn't in the catalog? We can help!
Reply Retweet Like
Abyntek Biopharma 22h
Immunization with merozoite surface protein 2 fused to a Plasmodium-specific carrier protein elicits strain-specific and strain-transcending, opsonizing antibody
Reply Retweet Like
Next Gen Therapeutics Jun 20
European antibody therapeutic companies are far more likely to manufacture both internally and externally (43%) compared to their North American counterparts, who tend to pick one or the other, with just 21% using both
Reply Retweet Like
Giancarlo 16h
join us in contributing to validation & experimental reproducibilty
Reply Retweet Like
Michael Heidorn Jun 23
Using Knockdowns to Verify Specificity
Reply Retweet Like
A. Vroom - Ten Wolde 23h
Potential drugs used in the –drug conjugate () architecture for therapy - Yaghoubi - - Journal of Cellular Physiology - Wiley Online Library
Reply Retweet Like
Discovery on Target 19h
Hear Jonny Finlay of Ultrahuman present “Paratope Refinement to Mitigate Antibody Polyspecificity” this September at . Learn more at
Reply Retweet Like
Giancarlo Jun 23
Created by scientists, our platform supports bench with sharing & validation data in an open & unbiased process
Reply Retweet Like
Cell Signaling Technology Jun 21
🕵️Investigate the role of Semaphorin-4D/CD100 in the immunosuppressive TME with this NEW IHC-validated rabbit monoclonal 53108.
Reply Retweet Like
ACIR.org Jun 20
Spotlight: (Original article published in ) Read our full digest at
Reply Retweet Like
Bio-Rad Antibodies Jun 17
Want to be the first to hear the latest news from Bio-Rad? Sign up to receive our emails including our new 'Fab Fragments' newsletter.
Reply Retweet Like
Sola Charles Jun 20
Anti medications: Remdesivir (GS-5734), an drug developed by Gilead Sciences, Inc; (monoclonal treatment developed by Mapp Biopharma Inc; REGN-EB3 (REGN3470-3471-3479), a monoclonal antibody cocktail developed by Regeneron Pharma Inc
Reply Retweet Like
Novasep 24h
We are exhibiting at the in ! Meet us at booth 4 today and tomorrow to discuss your mAb development and manufacturing challenges
Reply Retweet Like
Carterra Jun 18
Carterra's Tim Germann speaking to Rizwan Chaudhrey while at in Amsterdam last week, highlighting the excitement around Caterra's high-throughput platform including Epitope and Kinetic software capabilities.
Reply Retweet Like
A. Vroom - Ten Wolde Jun 18
THE ‐DRUG CONJUGATE () LONCASTUXIMAB TESIRINE (ADCT‐402) TARGETING CD19 SHOWS STRONG IN VITRO ANTI‐LYMPHOMA ACTIVITY BOTH AS SINGLE AGENTS AND IN COMBINATION - Tarantelli - 2019 - Hematological Oncology - Wiley Online Library
Reply Retweet Like